Abstract
摘要
相似文献
1
Sulfhemoglobinemia.
Iryo. 1972 Mar;26(3):194-203.
2
Sulfhemoglobinemia. Clinical and molecular aspects.
N Engl J Med. 1984 Jun 14;310(24):1579-84. doi: 10.1056/NEJM198406143102407.
3
Determination of aberrant hemoglobin derivatives in human blood.
Methods Enzymol. 1981;76:715-31. doi: 10.1016/0076-6879(81)76153-6.
4
Sulfhemoglobinemia after dermal application of DMSO.
Vet Hum Toxicol. 1998 Apr;40(2):87-9.
5
[Sulfhemoglobin--clinical significance and methods of determination].
Vojnosanit Pregl. 1969 Jul-Aug;26(7):355-7.
6
Identification of sulfhemoglobinemia after surgical polypectomy.
Clin Toxicol (Phila). 2007;45(2):189-92. doi: 10.1080/15563650601006066.
7
Sulfhemoglobin under the spotlight - Detection and characterization of SHb and HbFe-SH.
Biochim Biophys Acta Mol Cell Res. 2023 Jan;1870(1):119378. doi: 10.1016/j.bbamcr.2022.119378. Epub 2022 Oct 8.
8
[Formation of sulfhemoglobin using various drugs].
Nihon Yakurigaku Zasshi. 1975 May;71(4):351-65.
9
[Clinical significance of sulfhemoglobin analysis in blood cell chemical analysis].
Nihon Rinsho. 1989 Dec;48 Suppl:989-91.
10
Phenazopyridine-induced sulfhemoglobinemia.
Ann Pharmacother. 2005 Jun;39(6):1128-30. doi: 10.1345/aph.1E557. Epub 2005 May 10.
Zotero 插件